Lobbying activity

Q2

TODD STRATEGY GROUP for ALEXION PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $80,000.00 income

Medicare/Medicaid, Health Issues

View → Q2

BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $100,000.00 income

Health Issues

View → Q2

DLA PIPER LLP (US) for NOVARTIS

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income

Pharmacy, Medical/Disease Research/Clinical Labs, Copyright/Patent/Trademark, Taxation/Internal Revenue Code

View → Q2

HEALTHCARE LEADERSHIP COUNCIL for HEALTHCARE LEADERSHIP COUNCIL

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid

View → Q2

FORBES-TATE for IONIS PHARMACEUTICAL, INC.

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $30,000.00 income

Health Issues, Medicare/Medicaid

View → Q2

FORBES-TATE for NOVARTIS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Budget/Appropriations

View → Q2

IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q2

LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $20,000.00 income

Health Issues

View → Q2

LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $30,000.00 income

Medicare/Medicaid

View → Q2

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate

Health Issues

View → Q1

AMGEN, INC. for AMGEN INC

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

View → Q1

THE MCMANUS GROUP for GENENTECH

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code

View → Q1

THE MCMANUS GROUP for ALNYLAM PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q1

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Agriculture, Animals, Budget/Appropriations, Chemicals/Chemical Industry

View → Q1

BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $70,000.00 income

Health Issues

View → Q1

SPLITOAK STRATEGIES LLC for ALNYLAM PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q1

AVENUE SOLUTIONS for VERTEX PHARMACEUTICALS INCORPORATED

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

AVENUE SOLUTIONS for MERCK & CO. INC.

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid

View → Q1

TODD STRATEGY GROUP for NOVARTIS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid

View → Q1

BGR GOVERNMENT AFFAIRS for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid

View → Q1

NOVARTIS for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q1

TODD STRATEGY GROUP for ALEXION PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $80,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $20,000.00 income

Health Issues, Medicare/Medicaid

View → Q1

LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $30,000.00 income

Medicare/Medicaid

View →